Proqr Therapeutics N V (PRQR)

Nov 03, 2025

ProQR Advances AX-0810 into Clinical Trials for Cholestatic Diseases - TipRanks

Nov 03, 2025

Nov 03, 2025

Transcript : ProQR Therapeutics N.V.Shareholder/Analyst Call - MarketScreener

Nov 03, 2025

Nov 03, 2025

Can ProQR Therapeutics N.V. (0PQ) stock ride next bull market cycleJuly 2025 Price Swings & Reliable Momentum Entry Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Is ProQR Therapeutics N.V. stock a good choice for value investors2025 Short Interest & Daily Technical Stock Forecast Reports - newser.com

Nov 03, 2025

Nov 03, 2025

How ProQR Therapeutics N.V. (0PQ) stock compares with tech leadersJuly 2025 Selloffs & Verified Trade Idea Suggestions - newser.com

Nov 03, 2025

Nov 03, 2025

Why ProQR Therapeutics N.V. is moving todayJuly 2025 Gainers & Weekly Sector Rotation Insights - newser.com

Nov 03, 2025

Nov 03, 2025

Custom watchlist performance reports with ProQR Therapeutics N.V.Weekly Stock Summary & Technical Confirmation Trade Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Does ProQR Therapeutics N.V. stock trade at a discount to peers - newser.com

Nov 03, 2025

Nov 03, 2025

Will ProQR Therapeutics N.V. stock outperform international peersWeekly Risk Summary & AI Powered Market Trend Analysis - newser.com

Nov 03, 2025

Nov 03, 2025

Will ProQR Therapeutics N.V. stock gain from government policiesMarket Volume Report & Stock Timing and Entry Methods - newser.com

Nov 03, 2025

Nov 03, 2025

Using Bollinger Bands to evaluate ProQR Therapeutics N.V.July 2025 Big Picture & Step-by-Step Swing Trade Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Earnings visualization tools for ProQR Therapeutics N.V.2025 Earnings Surprises & Stepwise Entry and Exit Trade Signals - newser.com

Nov 03, 2025

Nov 03, 2025

ProQR Therapeutics N.V. (NASDAQ:PRQR) Short Interest Up 80.2% in October - Defense World

Nov 03, 2025

Nov 03, 2025

Is ProQR Therapeutics N.V. stock attractive for growth ETFsMarket Movers & Weekly Consistent Profit Watchlists - newser.com

Nov 03, 2025

Nov 03, 2025

Is ProQR Therapeutics N.V. stock cheap at current valuationJuly 2025 Momentum & Low Risk High Reward Trade Ideas - newser.com

Nov 03, 2025

Nov 03, 2025

Why analysts recommend ProQR Therapeutics N.V. (0PQ) stockQuarterly Trade Summary & Weekly High Return Stock Opportunities - newser.com

Nov 03, 2025

Nov 02, 2025

What catalysts could drive ProQR Therapeutics N.V. stock higherWeekly Loss Report & Consistent Return Strategy Ideas - newser.com

Nov 02, 2025

Nov 02, 2025

Key metrics from ProQR Therapeutics N.V.’s quarterly dataMarket Risk Summary & Safe Swing Trade Setup Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

How sentiment analysis helps forecast ProQR Therapeutics N.V.2025 Top Gainers & AI Enhanced Trading Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

ProQR Therapeutics N.V. (NASDAQ:PRQR) Short Interest Update - MarketBeat

Nov 02, 2025

Nov 02, 2025

What’s the recovery path for long term holders of ProQR Therapeutics N.V.July 2025 Snapshot & Daily Profit Focused Screening - newser.com

Nov 02, 2025

Nov 02, 2025

ProQR Therapeutics N.V. (NASDAQ:PRQR) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World

Nov 02, 2025

Nov 01, 2025

Visualizing ProQR Therapeutics N.V. stock with heatmapsTrade Entry Summary & Long Hold Capital Preservation Tips - newser.com

Nov 01, 2025

Oct 31, 2025

ProQR Therapeutics NV expected to post a loss of 10 cents a shareEarnings Preview - TradingView

Oct 31, 2025

Oct 31, 2025

ProQR Therapeutics (PRQR) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

Oct 31, 2025

Oct 31, 2025

Is ProQR Therapeutics N.V. (0PQ) stock at risk of policy regulation2025 Top Gainers & AI Enhanced Trading Alerts - newser.com

Oct 31, 2025

Oct 30, 2025

ProQR Therapeutics (NASDAQ:PRQR) Stock Passes Above 50-Day Moving AverageTime to Sell? - MarketBeat

Oct 30, 2025